Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma

Abstract

Background: Immunotherapy has revolutionized the treatment of clear cell renal cell carcinoma (ccRCC). However, the therapy is constrained by drug resistance. Therefore, further characterization of immune infiltration in ccRCC is needed to improve its efficacy. Methods: Here, we adopted the CIBERSORT method to analyze the level of 22 immune cells, and analyzed the correlation of immune cells and clinical parameters in ccRCC in The Cancer Genome Atlas. We used consensus clustering to cluster ccRCC and identified differently expressed genes (DEGs) between hot and cold tumors using the "Limma" package, and then performed enrichment analysis of DEGs. Finally, we constructed and validated a Cox regression model using the "survival", "glmnet", and "survivalROC" packages, implemented in R. Results: Regulatory T cells upregulated in tumor tissue increased during tumor progression, and correlated with poor overall survival in ccRCC. Consensus clustering identified four clusters of ccRCC. To elucidate the underlying mechanisms of immune cell infiltration, we subdivided these four clusters into two major types, immune hot and cold, and identified DEGs between them. The results revealed different transcription profiles in the two tumor types, with hot tumors being enriched in immune-related signaling, whereas cold tumors were enriched in extracellular matrix remodeling and the phosphatidylinositol 3-kinase-AKT (PI3K/AKT) pathway. We further identified hub genes and prognosticrelated genes from the DEGs, and constructed a Cox regression model for predicting the overall survival of patients with ccRCC. The areas under the receiver operating characteristics curve for the risk model for the training, testing, and external Zhengzhou validation cohorts were 0.834, 0.733, and 0.812, respectively. Notably, gene sets in the prediction model could also predict the overall survival of patients receiving immunotherapy. Conclusion: These findings provide a comprehensive characterization of immune infiltration in ccRCC, while the constructed model can be used effectively to predict the overall survival of ccRCC patients.

Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

“…Evidence shows that the tumor microenvironment significantly affects tumor diagnosis, survival outcomes, and clinical treatment sensitivity (21,23,(33)(34)(35). In recent years, related immunological studies have found that immune cell infiltration plays a key role in the tumor microenvironment in the formation, occurrence and development (31,(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47). The most concerned are the immune checkpoint protein PD-1 and its ligands PD-L1 and PDCD1LG2, tumor transforming growth factor B1 (TGFB1) and its receptors TGFB1R (48)(49)(50)(51)(52)(53)(54).…”

The Risk Correlation between N7-Methylguanosine Modification-Related lncRNAs and Survival Prognosis of Oral Squamous Cell Carcinoma Based on Comprehensive Bioinformatics Analysis

“…The larger the area under ROC curve (AUC), the higher the diagnostic accuracy of the test [ 38 ]. To test the predictive performance of OSCC prognostic risk score model, R package survival ROC was used to perform KM analysis on patients' survival time, survival status, risk score, and clinical characteristics (age, gender, tumor stage, and grade), and ROC curves of risk score and clinical traits were plotted [ 39 , 40 ].…”

A 9‐gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co‐expression and regression analyses

“…Samples were classified into high‐ and low‐risk groups with the median value of risk score as a cutoff, followed by a survival analysis through R package “survival” (Kumar et al, 2020). R package “survivalROC” (Zheng et al, 2021) was utilized to plot receiver operating characteristic (ROC) curves to compute AUC and C‐index values of 3‐year overall survival (OS) of patients predicted by risk assessment model.…”